ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 10 | April 12, 1974

Download PDF Visit The Full Archive

Related Articles

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998

NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC

September 6, 1996

Trial: Decitabine Improves Survival in Myeloid Leukemia

July 29, 2011

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008